Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Acrivon Therapeutics
Artios Pharma Ltd
Ensem Therapeutics
Eli Lilly and Company
AstraZeneca
Memorial Sloan Kettering Cancer Center
Faeth Therapeutics
AstraZeneca
Johns Hopkins University
VA Office of Research and Development
Totus Medicines
Zhuhai Yufan Biotechnologies Co., Ltd